Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 21, 2011, Pages 11862-11871

  Chen, Yu Kuo ^a   Cheung, Connie ^a   Reuhl, Kenneth R ^a   Liu, Anna Ba ^a   Lee, Mao Jung ^a   Lu, Yao Ping ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

EGCG; hepatic steatosis; high fat Western style diet; metabolic syndrome; obesity

Indexed keywords

EGCG; HEPATIC STEATOSIS; HIGH-FAT/WESTERN-STYLE DIET; METABOLIC SYNDROMES; OBESITY;

AMINO ACIDS; ANTHROPOMETRY; GLUCOSE; MAMMALS; METABOLISM;

NUTRITION;

CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; PLANT EXTRACT; POLYPHENOL;

ANIMAL; ARTICLE; BODY WEIGHT; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; LIPID DIET; MALE; METABOLIC SYNDROME X; METABOLISM; MOUSE; OBESITY; PATHOPHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CATECHIN; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HUMANS; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; OBESITY; PLANT EXTRACTS; POLYPHENOLS;

MUS;

EID: 80455140635     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf2029016     Document Type: Article

References (54)

1. Despres, J. P.; Lemieux, I. Abdominal obesity and metabolic syndrome Nature 2006, 444, 881-887
2. Ross, R.; Despres, J. P. Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise Obesity 2009, 17 (Suppl 3) S1-2
3. Daskalopoulou, S. S.; Mikhailidis, D. P.; Elisaf, M. Prevention and treatment of the metabolic syndrome Angiology 2004, 55, 589-612
4. Newmark, H. L.; Yang, K.; Lipkin, M.; Kopelovich, L.; Liu, Y.; Fan, K.; Shinozaki, H. A. Western-style diet induces benign and malignant neoplasms in the colon of normal C57BL/6 mice Carcinogenesis 2001, 22, 1871-1875
5. Newmark, H. L.; Yang, K.; Kurihara, N.; Fan, K.; Augenlicht, L. H.; Lipkin, M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer Carcinogenesis 2009, 30, 88-92
6. Yang, K.; Kurihara, N.; Fan, K.; Newmark, H.; Rigas, B.; Bancroft, L.; Corner, G.; Livote, E.; Lesser, M.; Edelmann, W.; Velcich, A.; Lipkin, M.; Augenlicht, L. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer Cancer Res. 2008, 68, 7803-7810
7. Erdelyi, I.; Levenkova, N.; Lin, E. Y.; Pinto, J. T.; Lipkin, M.; Quimby, F. W.; Holt, P. R. Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer J. Nutr. 2009, 139, 2072-2078
8. Yang, C. S.; Wang, X.; Lu, G.; Picinich, S. C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance Nat. Rev. Cancer 2009, 9, 429-439
9. Sae-Tan, S.; Grove, K. A.; Lambert, J. D. Laboratory studies on weight control and prevention of metabolic syndrome by green tea Pharmacol. Res. 2010, 64 (2) 146-154
10. Hininger-Favier, I.; Benaraba, R.; Coves, S.; Anderson, R. A.; Roussel, A. M. Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat J. Am. Coll. Nutr. 2009, 28, 355-361
11. Wolfram, S.; Raederstorff, D.; Preller, M.; Wang, Y.; Teixeira, S. R.; Riegger, C.; Weber, P. Epigallocatechin gallate supplementation alleviates diabetes in rodents J. Nutr. 2006, 136, 2512-2518
12. Lambert, J. D.; Yang, C. S. Mechanisms of cancer prevention by tea constituents J. Nutr. 2003, 133, 3262S-3267S
13. Wolfram, S.; Wang, Y.; Thielecke, F. Anti-obesity effects of green tea: from bedside to bench Mol. Nutr. Food Res. 2006, 50, 176-187
14. Thielecke, F.; Boschmann, M. The potential role of green tea catechins in the prevention of the metabolic syndrome: a review Phytochemistry 2009, 70, 11-24
15. Westerterp-Plantenga, M. S.; Lejeune, M. P.; Kovacs, E. M. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation Obes. Res. 2005, 13, 1195-1204
16. Nagao, T.; Komine, Y.; Soga, S.; Meguro, S.; Hase, T.; Tanaka, Y.; Tokimitsu, I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men Am. J. Clin. Nutr. 2005, 81, 122-129
17. Kao, Y. H.; Hiipakka, R. A.; Liao, S. Modulation of obesity by a green tea catechin Am. J. Clin. Nutr. 2000, 72, 1232-1234
18. Klaus, S.; Pultz, S.; Thone-Reineke, C.; Wolfram, S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation Int. J. Obes. 2005, 29, 615-623
19. Wolfram, S.; Raederstorff, D.; Wang, Y.; Teixeira, S. R.; Elste, V.; Weber, P. TEAVIGO(epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass Ann. Nutr. Metab. 2005, 49, 54-63
20. Wu, L. Y.; Juan, C. C.; Ho, L. T.; Hsu, Y. P.; Hwang, L. S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats J. Agric. Food Chem. 2004, 52, 643-648
21. Tsuneki, H.; Ishizuka, M.; Terasawa, M.; Wu, J. B.; Sasaoka, T.; Kimura, I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic(db/db) mice and on glucose metabolism in healthy humans BMC Pharmacol. 2004, 4, 18
22. Potenza, M. A.; Marasciulo, F. L.; Tarquinio, M.; Tiravanti, E.; Colantuono, G.; Federici, A.; Kim, J. A.; Quon, M. J.; Montagnani, M. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1378-1387
23. Sass, D. A.; Chang, P.; Chopra, K. B. Nonalcoholic fatty liver disease: a clinical review Dig. Dis. Sci. 2005, 50, 171-180
24. Farrell, G. C.; Larter, C. Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 2006, 43, S99-S112
25. Bruno, R. S.; Dugan, C. E.; Smyth, J. A.; DiNatale, D. A.; Koo, S. I. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury J. Nutr. 2008, 138, 323-331
26. Bose, M.; Lambert, J. D.; Ju, J.; Reuhl, K. R.; Shapses, S. A.; Yang, C. S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice J. Nutr. 2008, 138, 1677-1683
27. Zeisel, S. H.; Da Costa, K. A.; Franklin, P. D.; Alexander, E. A.; Lamont, J. T.; Sheard, N. F.; Beiser, A. Choline, an essential nutrient for humans FASEB J. 1991, 5, 2093-2098
28. Buchman, A. L.; Dubin, M. D.; Moukarzel, A. A.; Jenden, D. J.; Roch, M.; Rice, K. M.; Gornbein, J.; Ament, M. E. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation Hepatology 1995, 22, 1399-1403
29. Zeisel, S. H.; Blusztajn, J. K. Choline and human nutrition Annu. Rev. Nutr. 1994, 14, 269-296
30. Yao, Z. M.; Vance, D. E. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes J. Biol. Chem. 1988, 263, 2998-3004
31. Yao, Z. M.; Vance, D. E. Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes J. Biol. Chem. 1989, 264, 11373-11380
32. Albright, C. D.; da Costa, K. A.; Craciunescu, C. N.; Klem, E.; Mar, M. H.; Zeisel, S. H. Regulation of choline deficiency apoptosis by epidermal growth factor in CWSV-1 rat hepatocytes Cell. Physiol. Biochem. 2005, 15, 59-68
33. Zeisel, S. H.; da Costa, K. A.; Albright, C. D.; Shin, O. H. Choline and hepatocarcinogenesis in the rat Adv. Exp. Med. Biol. 1995, 375, 65-74
34. Nomura, S.; Ichinose, T.; Jinde, M.; Kawashima, Y.; Tachiyashiki, K.; Imaizumi, K. Tea catechins enhance the mRNA expression of uncoupling protein 1 in rat brown adipose tissue J. Nutr. Biochem. 2008, 19, 840-847
35. Park, H. S.; Lee, K. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity Diabetic Med. 2005, 22, 266-272
36. Zamboni, M.; Armellini, F.; Turcato, E.; Todesco, T.; Bissoli, L.; Bergamo-Andreis, I. A.; Bosello, O. Effect of weight loss on regional body fat distribution in premenopausal women Am. J. Clin. Nutr. 1993, 58, 29-34
37. Lin, C. L.; Lin, J. K. Epigallocatechin gallate(EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells Mol. Nutr. Food Res. 2008, 52, 930-939
38. Qin, B.; Polansky, M. M.; Harry, D.; Anderson, R. A. Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats Mol. Nutr. Food Res. 2010, 54 (Suppl 1) S14-23
39. Koyama, Y.; Abe, K.; Sano, Y.; Ishizaki, Y.; Njelekela, M.; Shoji, Y.; Hara, Y.; Isemura, M. Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo Planta Med. 2004, 70, 1100-1102
40. Morino, K.; Petersen, K. F.; Shulman, G. I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction Diabetes 2006, 55 (Suppl 2) S9-S15
41. Samuel, V. T.; Liu, Z. X.; Qu, X.; Elder, B. D.; Bilz, S.; Befroy, D.; Romanelli, A. J.; Shulman, G. I. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease J. Biol. Chem. 2004, 279, 32345-32353
42. Waltner-Law, M. E.; Wang, X. L.; Law, B. K.; Hall, R. K.; Nawano, M.; Granner, D. K. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production J. Biol. Chem. 2002, 277, 34933-34940
43. Koo, M. W.; Cho, C. H. Pharmacological effects of green tea on the gastrointestinal system Eur. J. Pharmacol. 2004, 500, 177-185
44. Koo, S. I.; Noh, S. K. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect J. Nutr. Biochem. 2007, 18, 179-183
45. Loest, H. B.; Noh, S. K.; Koo, S. I. Green tea extract inhibits the lymphatic absorption of cholesterol and alpha-tocopherol in ovariectomized rats J. Nutr. 2002, 132, 1282-1288
46. Wang, S.; Noh, S. K.; Koo, S. I. Green tea catechins inhibit pancreatic phospholipase A(2) and intestinal absorption of lipids in ovariectomized rats J. Nutr. Biochem. 2006, 17, 492-498
47. Wang, S.; Noh, S. K.; Koo, S. I. Epigallocatechin gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats J. Nutr. 2006, 136, 2791-2796
48. Yang, H.; Youm, Y. H.; Vandanmagsar, B.; Ravussin, A.; Gimble, J. M.; Greenway, F.; Stephens, J. M.; Mynatt, R. L.; Dixit, V. D. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance J. Immunol. 2010, 185, 1836-1845
49. van Wijk, J. P.; Rabelink, T. J. PPAR-gamma agonists: shifting attention from the belly to the heart? Arterioscler., Thromb., Vasc. Biol. 2004, 24, 798-800
50. Hauner, H. Secretory factors from human adipose tissue and their functional role Proc. Nutr. Soc. 2005, 64, 163-169
51. Kanda, H.; Tateya, S.; Tamori, Y.; Kotani, K.; Hiasa, K.; Kitazawa, R.; Kitazawa, S.; Miyachi, H.; Maeda, S.; Egashira, K.; Kasuga, M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J. Clin. Invest. 2006, 116, 1494-1505
52. Skurk, T.; Alberti-Huber, C.; Hauner, H. Effect of conditioned media from mature human adipocytes on insulin-stimulated Akt/PKB phosphorylation in human skeletal muscle cells: role of BMI and fat cell size Horm. Metab. Res. 2009, 41, 190-196
53. Kahn, S. E.; Zinman, B.; Haffner, S. M.; O'Neill, M. C.; Kravitz, B. G.; Yu, D.; Freed, M. I.; Herman, W. H.; Holman, R. R.; Jones, N. P.; Lachin, J. M.; Viberti, G. C. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes Diabetes 2006, 55, 2357-2364
54. Aronson, D.; Bartha, P.; Zinder, O.; Kerner, A.; Markiewicz, W.; Avizohar, O.; Brook, G. J.; Levy, Y. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome Int. J. Obes. 2004, 28, 674-679